Company news
Maravai Lifesciences Holdings, Inc. (NASDAQ:MRVI) news
Maravai Lifesciences Holdings, Inc. news releases on 6ix. Latest, Mar 12, 2024: Maravai LifeSciences Announces March 2024 Investor Conference Schedule
Press releases — page 2
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
March 11, 2024
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
February 20, 2024
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
January 28, 2024
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
November 8, 2023
Maravai LifeSciences Reports Third Quarter 2023 Financial Results
November 6, 2023
TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’
November 1, 2023
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
October 16, 2023
Maravai LifeSciences Hosts 2023 Investor R&D Day
September 28, 2023
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
September 18, 2023
Maravai LifeSciences to Host 2023 Investor R&D Day
September 4, 2023
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
August 22, 2023
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
August 8, 2023
Maravai LifeSciences Reports Second Quarter 2023 Financial Results
August 6, 2023
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
July 26, 2023
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
July 23, 2023
Maravai LifeSciences Announces Appointment of New Director to the Board
July 19, 2023
Congressman Scott Peters Tours Maravai’s RNA manufacturing facility
June 5, 2023
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
May 23, 2023
TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog
May 8, 2023
Maravai LifeSciences Reports First Quarter 2023 Financial Results
May 7, 2023
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
April 16, 2023
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
March 27, 2023
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
March 7, 2023
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
January 31, 2023
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
November 30, 2022
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
November 15, 2022
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
November 6, 2022
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
November 2, 2022
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
November 1, 2022
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
October 18, 2022
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
October 17, 2022
Maravai LifeSciences Announces CEO Leadership Transition
October 2, 2022
TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product
September 12, 2022
Maravai LifeSciences Announces September 2022 Investor Conference Schedule
August 14, 2022
Maravai Lifesciences Reports Second Quarter 2022 Financial Results
August 3, 2022
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022
July 18, 2022
TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team
July 5, 2022
Maravai LifeSciences Strengthens Executive Leadership Team to Support Long-Term Growth
June 26, 2022
TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense
May 23, 2022
Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule
May 10, 2022
Maravai LifeSciences Reports First Quarter 2022 Financial Results
May 4, 2022
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022
April 20, 2022
BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY
April 11, 2022
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
March 8, 2022
Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance
February 22, 2022
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
January 27, 2022
Maravai LifeSciences Announces Upcoming Investor Events
January 24, 2022
Maravai LifeSciences Announces Debt Repricing
January 19, 2022